Troy Lister insider trades
Open-market stock purchases and sales by Troy Lister, Chief Scientific Officer at Verve Therapeutics, Inc, from SEC Form 4 filings since Jun 21, 2024.
Recent trades
No open-market trades in the last 12 months.
Companies traded
- VERV Verve Therapeutics, Inc: 1 sale, last Jul 25, 2025